KGDZX | RSLCX | KGDZX / RSLCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 22 years | - |
Gain YTD | 10.153 | 6.729 | 151% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 172M | 77.1B | 0% |
Annual Yield % from dividends | 0.95 | 0.45 | 212% |
Returns for 1 year | 22.55 | 22.27 | 101% |
Returns for 3 years | -17.44 | -22.12 | 79% |
Returns for 5 years | 17.83 | 24.71 | 72% |
Returns for 10 years | -17.63 | 45.68 | -39% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 65.66 | 1.23 | +1.91% |
ProShares Ultra Nasdaq Biotechnology | |||
FOVL | 70.91 | 0.88 | +1.25% |
iShares Focused Value Factor ETF | |||
XLF | 47.48 | 0.58 | +1.24% |
The Financial Select Sector SPDR® ETF | |||
RWX | 26.61 | 0.17 | +0.64% |
SPDR® Dow Jones® International RelEstETF | |||
SUSC | 23.56 | 0.06 | +0.26% |
iShares ESG USD Corporate Bond ETF |